Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heart Failure with Preserved Ejection Fraction—a Concise Review
Daria Adamczak, Mary-Tiffany Oduah, Thomas Kiebalo, et al.
Current Cardiology Reports (2020) Vol. 22, Iss. 9
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF)
Darshan Hullon, Ghasaq K. Subeh, Yu.V. Volkova, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Epidemiology and pathogenesis of heart failure with preserved ejection fraction
Nandini Nair
Reviews in Cardiovascular Medicine (2020) Vol. 21, Iss. 4
Open Access | Times Cited: 91
Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility
Volker Adams, Antje Schauer, Antje Augstein, et al.
Journal of Cachexia Sarcopenia and Muscle (2022) Vol. 13, Iss. 3, pp. 1565-1581
Open Access | Times Cited: 41
Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach
Laurențiu Stoicescu, Dana Crișan, Claudiu Morgovan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 794-794
Open Access | Times Cited: 14
Psoriatic arthritis and the association with cardiometabolic disease: a narrative review
Paras Karmacharya, Alexis Ogdie, Lihi Eder
Therapeutic Advances in Musculoskeletal Disease (2021) Vol. 13
Open Access | Times Cited: 54
Empagliflozin Improves Diastolic Function in HFpEF by Restabilizing the Mitochondrial Respiratory Chain
Antje Schauer, Volker Adams, Susanne Kämmerer, et al.
Circulation Heart Failure (2024) Vol. 17, Iss. 6
Open Access | Times Cited: 8
Defining cardiac involvement in idiopathic inflammatory myopathies: a systematic review
Jessica Fairley, Ian P. Wicks, Stacey Peters, et al.
Lara D. Veeken (2021) Vol. 61, Iss. 1, pp. 103-120
Closed Access | Times Cited: 29
Empagliflozin Preserves Skeletal Muscle Function in a HFpEF Rat Model
Ephraim B. Winzer, Antje Schauer, Erik Langner, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 10989-10989
Open Access | Times Cited: 22
Identifying distinct clinical clusters in heart failure with mildly reduced ejection fraction
Claartje M.E.M. Meijs, Jasper J. Brugts, Lars H. Lund, et al.
International Journal of Cardiology (2023) Vol. 386, pp. 83-90
Open Access | Times Cited: 12
Phenomics and Robust Multiomics Data for Cardiovascular Disease Subtyping
Enrico Maiorino, Joseph Loscalzo
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 7, pp. 1111-1123
Open Access | Times Cited: 12
Modeling Heart Failure With Preserved Ejection Fraction Using Human Induced Pluripotent Stem Cell–Derived Cardiac Organoids
Idan Refael Haim, Amit Gruber, Noam Kazma, et al.
Circulation Heart Failure (2025)
Closed Access
Deciphering the Molecular Mechanisms of QLQX Capsules in Heart Failure: A Multi-Omics Perspective
Jiameng Hao, Mingye Wang, Qiulan Wu, et al.
Phytomedicine (2025), pp. 156828-156828
Open Access
Defining the Phenotypes for Heart Failure With Preserved Ejection Fraction
Dane Rucker, Jacob Joseph
Current Heart Failure Reports (2022) Vol. 19, Iss. 6, pp. 445-457
Closed Access | Times Cited: 13
Insights into the Interaction of Heart Failure with Preserved Ejection Fraction and Sleep-Disordered Breathing
Michael Wester, Michael Arzt, Frederick Sinha, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 3038-3038
Open Access | Times Cited: 8
Heart Failure with Preserved Ejection Fraction and Obstructive Sleep Apnea: A Novel Paradigm for Additional Cardiovascular Benefit of SGLT2 Inhibitors in Subjects With or Without Type 2 Diabetes
Vincenzo Maria Monda, Sandro Gentile, Francesca Porcellati, et al.
Advances in Therapy (2022) Vol. 39, Iss. 11, pp. 4837-4846
Open Access | Times Cited: 12
Exploring the Cardiorenal Benefits of SGLT2i: A Comprehensive Review
Angelica Cersosimo, Andrea Drera, Marianna Adamo, et al.
Kidney and Dialysis (2024) Vol. 4, Iss. 4, pp. 184-202
Open Access | Times Cited: 2
Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
Xinxin Zhang, Yuxi Sun, Yanli Zhang, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 15
β-Hydroxybutyrate inhibits cardiac microvascular collagen 4 accumulation by attenuating oxidative stress in streptozotocin-induced diabetic rats and high glucose treated cells
Huanli Qi, Lihui Gu, Dongmei Xu, et al.
European Journal of Pharmacology (2021) Vol. 899, pp. 174012-174012
Closed Access | Times Cited: 13
Obstructive sleep apnoea is associated with the development of diastolic dysfunction after myocardial infarction with preserved ejection fraction
Stefan Büchner, Michael Wester, Sarah Hobelsberger, et al.
Sleep Medicine (2022) Vol. 94, pp. 63-69
Open Access | Times Cited: 7
Echocardiographic evaluation of left ventricular end diastolic pressure in patients with diastolic heart failure
Fen Zhang, Yi Liang, Xinxin Chen, et al.
Medicine (2020) Vol. 99, Iss. 49, pp. e22683-e22683
Open Access | Times Cited: 8
Pharmacological mechanisms of sodium-glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction
Bo Liang, Yi Liang, Ning Gu
BMC Cardiovascular Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 5
In silico identification of potential calcium dynamics and sarcomere targets for recovering left ventricular function in rat heart failure with preserved ejection fraction
Stefano Longobardi, Anna Sher, Steven Niederer
PLoS Computational Biology (2021) Vol. 17, Iss. 12, pp. e1009646-e1009646
Open Access | Times Cited: 7
Heart Failure with Preserved Ejection Fraction: Pathogenesis, Diagnosis, Exercise, and Medical Therapies
Qingyi Zhan, Wenjing Peng, Siqi Wang, et al.
Journal of Cardiovascular Translational Research (2022) Vol. 16, Iss. 2, pp. 310-326
Closed Access | Times Cited: 5
Potential Benefits of Sodium-Glucose Transporter-2 Inhibitors in the Symptomatic and Functional Status of Patients With Heart Failure: A Systematic Review and Meta-Analysis
Sushen Bhalla, Yousif AlQabandi, Savitri Aninditha Nandula, et al.
Cureus (2022)
Open Access | Times Cited: 4
Assessing clinical and biomarker characteristics to optimize the benefits of sacubitril/valsartan in heart failure
Sheldon E. Litwin, Cara East
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top